CALCIUM-CHANNEL ANTAGONISTS AND HUMAN-IMMUNODEFICIENCY-VIRUS COAT PROTEIN-MEDIATED NEURONAL INJURY

被引:54
作者
LIPTON, SA
机构
[1] BETH ISRAEL HOSP,DEPT NEUROL,BOSTON,MA 02215
[2] BRIGHAM & WOMENS HOSP,DEPT NEUROL,BOSTON,MA 02115
[3] MASSACHUSETTS GEN HOSP,DEPT NEUROL,BOSTON,MA 02114
[4] HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02115
关键词
D O I
10.1002/ana.410300121
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recent evidence in vitro has suggested that neuronal injury observed in the acquired immunodeficiency syndrome dementia complex may depend, at least in part, on toxic effects of the human immunodeficiency virus type 1 envelope protein, gp120. This laboratory previously reported that members of the dihydropyridine class of calcium channel antagonists, nimodipine and nifedipine, greatly attenuate the rise in intracellular calcium engendered by gp 120 and prevent subsequent neuronal injury. The relatively low (nanomolar) concentrations of dihydropyridines that were effective suggested that their action might be exerted at the level of the L-type of voltage-dependent calcium channels. In the present study, I tested members of the three other major classes of Ca2+ channel antagonist drugs to determine if they too could prevent neurotoxicity induced by gp 120. At the maximal dose that did not cause neuronal damage in and of itself, a diphenylalkylamine piperazine derivative (flunarizine, 10-mu-M) was the most effective, a phenylalkylamine (verapamil, 100-mu-M) was possibly effective, whereas a benzothiazepine (diltiazem, 1-mu-M) was ineffectual in protecting rat retinal ganglion cells from gp 120-induced toxicity in vitro. To explain these results, previous work has shown that the various classes of Ca2+ channel antagonists may exhibit differential potency in blocking voltage-dependent Ca2+ current in neurons, with dihydropyridines and flunarizine being the most potent at neuronal calcium channels. Moreover, these channels on mammalian central neurons are relatively insensitive to agents such as verapamil and diltiazem compared with other cell types like muscle. The low micromolar concentrations necessary for potency of flunarizine is in keeping with that predicted by binding and electrophysiological studies for block of voltage-dependent calcium channels. Other mechanisms of neuroprotection by flunarizine from gp120, however, cannot be totally excluded.
引用
收藏
页码:110 / 114
页数:5
相关论文
共 27 条
[1]   PROTECTION FROM GENITAL HERPES-SIMPLEX VIRUS TYPE-2 INFECTION BY VACCINATION WITH CLONED TYPE-1 GLYCOPROTEIN-D [J].
BERMAN, PW ;
GREGORY, T ;
CRASE, D ;
LASKY, LA .
SCIENCE, 1985, 227 (4693) :1490-1492
[2]   NEURONAL CELL KILLING BY THE ENVELOPE PROTEIN OF HIV AND ITS PREVENTION BY VASOACTIVE INTESTINAL PEPTIDE [J].
BRENNEMAN, DE ;
WESTBROOK, GL ;
FITZGERALD, SP ;
ENNIST, DL ;
ELKINS, KL ;
RUFF, MR ;
PERT, CB .
NATURE, 1988, 335 (6191) :639-642
[3]   GLUTAMATE NEUROTOXICITY AND DISEASES OF THE NERVOUS-SYSTEM [J].
CHOI, DW .
NEURON, 1988, 1 (08) :623-634
[4]   HIV-1 COAT PROTEIN NEUROTOXICITY PREVENTED BY CALCIUM-CHANNEL ANTAGONISTS [J].
DREYER, EB ;
KAISER, PK ;
OFFERMANN, JT ;
LIPTON, SA .
SCIENCE, 1990, 248 (4953) :364-367
[5]   KINETIC AND PHARMACOLOGICAL PROPERTIES DISTINGUISHING 3 TYPES OF CALCIUM CURRENTS IN CHICK SENSORY NEURONS [J].
FOX, AP ;
NOWYCKY, MC ;
TSIEN, RW .
JOURNAL OF PHYSIOLOGY-LONDON, 1987, 394 :149-172
[6]   SECRETION OF NEUROTOXINS BY MONONUCLEAR PHAGOCYTES INFECTED WITH HIV-1 [J].
GIULIAN, D ;
VACA, K ;
NOONAN, CA .
SCIENCE, 1990, 250 (4987) :1593-1596
[7]  
GODFRAIND T, 1986, PHARMACOL REV, V38, P321
[8]   CALCIUM CHANNELS AND CALCIUM-CHANNEL ANTAGONISTS [J].
GREENBERG, DA .
ANNALS OF NEUROLOGY, 1987, 21 (04) :317-330
[9]   CENTRAL MAMMALIAN NEURONS NORMALLY RESISTANT TO GLUTAMATE TOXICITY ARE MADE SENSITIVE BY ELEVATED EXTRACELLULAR CA-2+ - TOXICITY IS BLOCKED BY THE N-METHYL-D-ASPARTATE ANTAGONIST MK-801 [J].
HAHN, JS ;
AIZENMAN, E ;
LIPTON, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (17) :6556-6560
[10]   THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) DEMENTIA COMPLEX [J].
HO, DD ;
BREDESEN, DE ;
VINTERS, HV ;
DAAR, ES .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (05) :400-410